Each month the CSF Steering Committee selects the latest published original articles on RA, PsA, and axSpA, focusing on those with data on therapeutic interventions and those that have clinical impact.
PsA Literature Highlights – August 2022
Secukinumab, Bimekizumab, Risankizumab, CHOICE, SELECT-PsA-1, SELECT-PsA-2
PsA Single Slide Summaries - July
Bimekizumab, Guselkumab, Ixekizumab, Apremilast, Secukinumab, General Health Outcomes
RA Single Slide Summaries – July 2022
Baricitinib, Tofacitinib, Skin Fibrosis, TNF Inhibition, Methotrexate
Single Slide Summaries – June 2022
TNF Inhibition, bDMARDs, tsDMARDs, Liver Injury, Tofacitinib, Filgotinib, JAK Inhibition
PsA Single Slide Summaries - June
Deucravacitinib, Ustekinumab, ACHILLES, Tofacitinib, SELECT-PsA 1, SELECT-PsA 2, Secukinumab, Guselkumab
AxSpA Single Slide Summaries - May
Ixekizumab, C-reactive Protein, Filgotinib, TORTUGA, Secukinumab, TNF Inhibition